Recent Advances in Multiple Myeloma: Highlights from the IMS 2022 Meeting and Beyond - Episode 7

Transplant-Ineligible Multiple Myeloma: The MAIA and SWOG 0777 Trials

, , , ,

Dr Larry Anderson summarizes the study design and updated data of the MAIA trial, and Dr Rebecca Silbermann compares it against the SWOG 0777 trial.